Autoantibodies and the risk of cardiovascular events. - Wikidata - wikimedia - TriplyDB

Autoantibodies and the risk of cardiovascular events.

Autoantibodies and the risk of cardiovascular events.

http://www.wikidata.org/entity/Q33721605

about

Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.Heart disease and rheumatoid arthritis: understanding the risks.Is atherosclerosis an autoimmune disease?Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis Extra-articular Manifestations in Rheumatoid Arthritis.Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients.Systemic lupus erythematosus and systemic autoimmune connective tissue disorders behind recurrent diastolic heart failure.Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: Analytical study in a specialized health institute, one year follow-up Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.Is preclinical autoimmunity benign?: The case of cardiovascular disease.The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.Can rheumatoid arthritis be prevented?Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Cardiovascular safety of biologic therapies for the treatment of RA.Rheumatoid arthritis and cardiovascular disease Atherosclerotic vascular disease in the autoimmune rheumatologic patient.Cardiovascular comorbidity in rheumatic diseases.Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis.Estimating the diagnostic accuracy of rheumatoid factor in UK primary care: a study using the Clinical Practice Research Datalink.Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea.Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis.Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?Autonomic impairment in rheumatoid arthritis.Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study.A role for autoantibodies in atherogenesis.Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study.

P2860

Q26744334-971BC041-7705-48E5-AFA6-DDDF2BF48791 Q26823443-B3121159-BF25-446D-9F8E-EDBD97D0C129 Q27003201-441A37B8-41FF-4116-8B4B-BC88DC5F1E98 Q30885473-CE5C0A32-4309-4C58-A22A-15935AAD0EE9 Q33771477-2991635C-AD26-4FE6-A2A0-4C00D0E6A290 Q33865776-A852EC63-D8DD-4738-B647-7E3BB44FE8CF Q34005307-27A596B7-0DB2-444D-8116-DAFF42EA3391 Q34746646-C8F72B33-3E2C-4DAC-BD49-84D75037E138 Q35019085-A5467E3B-6CE1-49C8-A8A3-9B04AF09F151 Q35123740-1B0E3B12-8D48-43BA-B55C-03FE28074A18 Q35152141-F527F6DE-BD7E-460F-8194-E83BE6657EF1 Q35154792-240BE8DF-0273-45D5-B890-4A9A2CC728DB Q35160608-71BFD3E6-79AA-4D6E-997F-606BFF2DF09D Q35224673-FAA50E99-2D07-4222-B63D-60F72E4A6CE4 Q35755442-E2C4949E-AE62-4973-A2A3-28C34E4E58BD Q36001551-4E96BD5C-BECE-414E-943F-64F506AF310E Q36222405-00C00C1D-C56B-4331-A3D0-90964AFD2245 Q36396428-8FBFF89F-0030-4851-80EA-A64CDF81B9DF Q36737988-70FE96AF-1FF5-46D9-A159-1208CE19281B Q36932166-3F01C8D3-5D2C-4D23-96BD-4C18A5D4DB19 Q37027093-21AFE249-F2CB-49A8-9BF6-AA4228426F44 Q37589108-041FF042-77EB-40B8-91EA-3A492429E2DD Q37782589-843C80C7-E660-4FB7-A4C9-79BCC36DA2A2 Q37786648-434C3306-5BCE-45EC-AFBD-2E79DF1B96F8 Q37883018-E546170F-27A7-4FA3-9109-93E485170A70 Q37956137-D6824E19-AE43-4C23-9DDD-75D5D302A349 Q38149252-8BB41996-0711-44C3-A98A-B542844B75A2 Q38365624-44AB58A7-945C-4B57-AAEF-7CBE13F7FC40 Q38568465-7D7EAAE8-8EBB-487E-88FE-6DE8834F9C48 Q39783377-29BE7EDF-F884-42CB-8957-4D29D0CF7719 Q40851421-8EFB605E-B17E-430A-9EB5-7D8BC7D18B1F Q41617609-21A12A31-2BB2-4DFD-8F22-567DA1514F2E Q41732431-B7122CE9-7922-4BC4-8101-B8DD6C2285EA Q42282781-7B89F2AA-CC64-4429-B0E9-90A727DC1B57 Q42708363-5DE4312E-1E53-46E1-A116-69194880FCCB Q44071398-08464C26-43CC-4C6B-80F4-4E2AF8A59772 Q46269700-88410AC9-1B36-4382-866B-5C11CEC90D4A Q46725210-80BBE59A-8897-4DBB-AFA5-1A4882C8FA3B Q47623831-C1D1952A-6E53-47C6-9D08-70A2D67178BD Q50285614-6244DFD3-39D3-471B-9FD9-23E0473FAFE1

P2860

Autoantibodies and the risk of cardiovascular events.

http://www.wikidata.org/entity/Q33721605

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Autoantibodies and the risk of cardiovascular events.

@ast

Autoantibodies and the risk of cardiovascular events.

@en

type

label

Autoantibodies and the risk of cardiovascular events.

@ast

Autoantibodies and the risk of cardiovascular events.

@en

prefLabel

Autoantibodies and the risk of cardiovascular events.

@ast

Autoantibodies and the risk of cardiovascular events.

@en

P1433

Q33721605-C3C16454-8F3F-4AF9-9D85-22D1626B9B9E

P1476

Q33721605-4F67D511-E9FD-46EE-B232-5CE1B45DC34E

P2093

Q33721605-041F8344-33AC-4E41-86EF-53061F38534B

Q33721605-23129CD1-6E49-431C-837F-F06BF43CF3AE

Q33721605-7E3E8EE3-B985-48B5-A961-BC578F7F4A11

Q33721605-A67050E3-07A0-4693-B8A2-9E48B3E187FE

Q33721605-BA6B6DB6-7718-4482-82AE-5C01D8EA8307

Q33721605-D4DD22BE-5BB9-4FBB-B250-CCDDE1FD4F9B

Q33721605-F49097B0-4EF7-420B-9C2D-06CA52FE813F

P2860

Q33721605-0CC09B94-6911-439E-AE7C-E3CF6FB5F9C2

Q33721605-12447E8D-F767-484F-ACF5-24EFABA06DCF

Q33721605-19DDC4EA-EBFC-4FF4-8354-314E6B73C680

Q33721605-2D9BE8B0-DC5E-4D16-B9E9-DDE1EFE9FA11

Q33721605-3F27BBA7-A29E-4955-8578-098F781EC9DB

Q33721605-4F5473A0-59B6-4BD2-842C-9AAFA3F29B96

Q33721605-598D51CE-062A-4636-AB59-EC75AB3C8C51

Q33721605-6B1736F6-F6F4-4297-90A5-CA3A15E255F9

Q33721605-9583E728-C8C7-4441-B148-F082D21D3391

Q33721605-98DE7EBB-D9CE-4D32-AB94-1A75404F5B03

P304

Q33721605-8CDDD286-947B-44B5-AB74-9E0F54FE9065

P31

Q33721605-248B7556-CE4A-474D-9910-00B688D5F41C

P356

Q33721605-9C70FB29-20D4-4D13-9B22-A7F7E79E65AA

P407

Q33721605-A6B0EC14-718E-45B4-96B1-72DC80BDC842

P433

Q33721605-970D3B50-4685-40DB-A6A7-CC50610636DC

P478

Q33721605-E566DDA8-2B9E-4F29-9946-1FF8ACC13D70

P577

Q33721605-F16CAE97-2E14-41DB-B201-475DC2FD3585

P5875

Q33721605-508E9C1C-7AF3-4BDD-9E2E-07452FDF2428

P698

Q33721605-A22EFC57-0832-4F33-8BBC-209D71E2047F

P921

Q33721605-CC598BB4-AC87-464C-B761-877FA06B389A

Q33721605-E64E5835-49B1-481F-907C-D1ADE1EB23D5

P932

Q33721605-2974EEB8-ECB3-4777-A952-C7F770DBFA15

P356

P1433

The Journal of Rheumatology

P1476

Autoantibodies and the risk of cardiovascular events.

@en

P2093

Cynthia S Crowson

http://www.w3.org/2001/XMLSchema#string

Hilal Maradit Kremers

http://www.w3.org/2001/XMLSchema#string

Kimberly P Liang

http://www.w3.org/2001/XMLSchema#string

Melissa R Snyder

http://www.w3.org/2001/XMLSchema#string

Sherine E Gabriel

http://www.w3.org/2001/XMLSchema#string

Terry M Therneau

http://www.w3.org/2001/XMLSchema#string

Veronique L Roger

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Rheumatoid factor, chronic arthritis and mortality.

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

The mortality of rheumatoid arthritis.

History of the Rochester Epidemiology Project.

Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.

P304

2462-2469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.090188

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38015013

http://www.w3.org/2001/XMLSchema#string

P698

19833748

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2837072

http://www.w3.org/2001/XMLSchema#string